2021
DOI: 10.1101/2021.01.10.21249524
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Using excess deaths and testing statistics to improve estimates of COVID-19 mortalities

Abstract: Factors such as non-uniform definitions of mortality, uncertainty in disease prevalence, and biased sampling complicate the quantification of fatality during an epidemic. Regardless of the employed fatality measure, the infected population and the number of infection-caused deaths need to be consistently estimated for comparing mortality across regions. We combine historical and current mortality data, a statistical testing model, and an SIR epidemic model, to improve estimation of mortality. We find that the … Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
3
2

Relationship

3
2

Authors

Journals

citations
Cited by 5 publications
(7 citation statements)
references
References 29 publications
0
7
0
Order By: Relevance
“…Previous studies have positively associated neuroticism, extroversion, and kindness with the perceived cost of complying with preventive measures, while awareness showed a negative association [59]. It has been proposed that, in countries where there are no reliable indicators to measure the number of people infected and dead by COVID-19, as is the case in many Latin American countries, the relative excess of deaths over the time period should be used as a more reliable indicator of the development of the disease [5].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Previous studies have positively associated neuroticism, extroversion, and kindness with the perceived cost of complying with preventive measures, while awareness showed a negative association [59]. It has been proposed that, in countries where there are no reliable indicators to measure the number of people infected and dead by COVID-19, as is the case in many Latin American countries, the relative excess of deaths over the time period should be used as a more reliable indicator of the development of the disease [5].…”
Section: Discussionmentioning
confidence: 99%
“…Latin America has overcome major recent health challenges such as Zika, but they were not as lethal as the current COVID-19, the Coronavirus Disease 2019 caused by SARS-CoV-2, with high rates of subclinical infections and inconsistent and insufficient diagnostic tests detected, making it difficult to know the actual number of people infected [4]. Analyzing deaths during 2020 in Peru, Ecuador, Mexico, and Spain, there were significantly greater excess deaths than the ones recorded for COVID-19, something that has not happened in Denmark, Germany, or Norway [5]. By the end of February 2020, Brazil became the first Latin American country to report the first case of COVID-19, followed by Ecuador, Argentina, and Chile.…”
Section: Introductionmentioning
confidence: 99%
“…For each infected compartment I, I , and I , we calculate the infection fatality ratios (IFRs) [3] by dividing the associated cumulative number of deaths by the total number of infections in the unvaccinated, prime-vaccinated, and prime-boost-vaccinated compartments, respectively. The IFR of the unvaccinated pool of individuals is…”
Section: Data and Code Availabilitymentioning
confidence: 99%
“…As of June 28, 2021, the number of confirmed COVID-19 cases exceeded 180 million and more than 3.9 million COVID-19 deaths in more than 219 countries were reported [2]. Large differences between excess deaths and reported COVID-19 deaths across different countries suggest that the actual death toll associated with COVID-19 is even higher [3].…”
Section: Introductionmentioning
confidence: 99%
“…Estimates of disease prevalence and other surveillance metrics [14,15] need to account for FPRs and FNRs, in particular if reported positive-testing rates [16] are in the few percent range and potentially dominated by type I errors. In addition to type-I/II testing errors, another confounding effect is biased testing [17], that is, preferential testing of individuals that are expected to carry a high viral load ( e.g ., symptomatic and hospitalized individuals).…”
Section: Introductionmentioning
confidence: 99%